Bausch Health Companies (BHC) Accumulated Expenses (2009 - 2026)

Bausch Health Companies has disclosed Accumulated Expenses across 18 years of filings, most recently posting $3.0 billion for Q1 2026.

• Accumulated Expenses for Q1 2026 came in at $3.0 billion, down 9.45% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.0 billion (down 9.45% YoY), and the FY2025 annual result was $3.3 billion, down 4.16% from the prior year.
• Accumulated Expenses came in at $3.0 billion for Q1 2026 at Bausch Health Companies, down from $3.3 billion in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $4.3 billion in Q2 2022 to a low of $2.9 billion in Q1 2023.
• The 5-year median for Accumulated Expenses is $3.3 billion (2024), against an average of $3.4 billion.
• Across the five-year window, Accumulated Expenses slumped 41.11% in 2022 and rose 11.36% in 2024, its largest moves.
• Bausch Health Companies' Accumulated Expenses stood at $3.0 billion in 2022, then rose by 4.85% to $3.1 billion in 2023, then increased by 11.36% to $3.5 billion in 2024, then fell by 4.16% to $3.3 billion in 2025, then declined by 9.18% to $3.0 billion in 2026.
• The last three Accumulated Expenses figures came in at $3.0 billion (Q1 2026), $3.3 billion (Q4 2025), and $3.6 billion (Q3 2025), per Business Quant data.